| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 02/02/2005 | EP1501807A1 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists |
| 02/02/2005 | EP1501805A1 Substituted pyrazolyl compounds for the treatment of inflammation |
| 02/02/2005 | EP1501803A2 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity |
| 02/02/2005 | EP1501801A1 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors |
| 02/02/2005 | EP1501800A1 Bombesin antagonists |
| 02/02/2005 | EP1501798A2 SULFONYLAMINOVALEROLAC TAMS AND DERIVATIVES THEREOF AS FACTOR Xa INHIBITORS |
| 02/02/2005 | EP1501797A1 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo[b]thiophene-2-carboxylic acid derivatives as interleukin-4 gene expression inhibitors |
| 02/02/2005 | EP1501796A1 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo[b]thiophene-2-carboxylic acid derivatives as interleukin-4 gene expression inhibitors |
| 02/02/2005 | EP1501795A1 Cinnamic acid amides |
| 02/02/2005 | EP1501514A2 Protein kinase modulators and methods of use |
| 02/02/2005 | EP1501513A2 Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists |
| 02/02/2005 | EP1501508A1 Inhibitors of histone deacetylase |
| 02/02/2005 | EP1501504A1 1-substituted imidazole derivatives as nos inhibitors |
| 02/02/2005 | EP1501467A2 Heterocyclo inhibitors of potassium channel function |
| 02/02/2005 | EP1501360A1 2,6 substituted pyridine-3-carbonyl derivatives serving as plant protection agents having herbicidal action |
| 02/02/2005 | EP1414814B1 6-aryl-4-aminopicolinates and their use as herbicides |
| 02/02/2005 | EP1379587B1 Long chain hindered amines and compositions stabilized therewith |
| 02/02/2005 | EP1303506B1 6-heteroarylphenanthridines |
| 02/02/2005 | EP1292591B1 Substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 02/02/2005 | EP1286955B1 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides |
| 02/02/2005 | EP0828754B1 Dipeptides which promote release of growth hormone |
| 02/02/2005 | CN1575291A Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist |
| 02/02/2005 | CN1575290A Pyrimidine derivatives and pharmaceutical compositions containing that compounds |
| 02/02/2005 | CN1575284A Substituted triazole diamine derivatives as kinase inhibitors |
| 02/02/2005 | CN1575283A Piperazine derivatives with CCRI receptor antagonist activity |
| 02/02/2005 | CN1575177A Cxcr3 antagonists |
| 02/02/2005 | CN1575176A Process for making substituted pyrazoles |
| 02/02/2005 | CN1575174A Pharmaceutically active isoindoline derivatives |
| 02/02/2005 | CN1575172A Substituted ideno[1, 2-c]isoquinoline derivatives and methods of use thereof |
| 02/02/2005 | CN1575171A Novel anti-diabetic agents |
| 02/02/2005 | CN1572792A Pyrazolo [4, 3-d] pyrimidine derivatives |
| 02/02/2005 | CN1572299A Agents for improving excretory potency of urinary bladder |
| 02/02/2005 | CN1187342C Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists |
| 02/02/2005 | CN1187338C 5-phenyl-pyrimidine derivatives |
| 02/02/2005 | CN1187333C Certain substituted caprolactams, pharmaceutical compositions containing them and their use in treating tumors |
| 02/02/2005 | CN1187331C Esters of 3-hydroxy-piperidinemethanol derivatives, pharmaceutical composition containing same and their preparation method and uses |
| 02/02/2005 | CN1187326C Novel compounds |
| 02/02/2005 | CN1187325C Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof |
| 02/01/2005 | US6849740 Antimicrobial quinolones, their compositions and uses |
| 02/01/2005 | US6849739 N-heterocyclic derivatives as NOS inhibitors |
| 02/01/2005 | US6849732 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation |
| 02/01/2005 | US6849713 Topisomerase inhibitor |
| 02/01/2005 | US6849660 Antimicrobial biaryl compounds |
| 02/01/2005 | US6849653 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 02/01/2005 | US6849648 Phenylene alkyne matrix metalloproteinase inhibitors |
| 02/01/2005 | US6849647 Amide compounds and medications containing the same technical field |
| 02/01/2005 | US6849644 For example, 7-(Indole-1-sulfonyl)-1,2,3,4-tetrahydro-isoquinoline; treatment of depression, anxiety, Alzheimers disease, age related cognitive decline, Attention Deficit Disorder |
| 02/01/2005 | US6849643 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 02/01/2005 | US6849639 Anticancer agents, antiinflamatory agents, osteoporosis, atherosclerosis |
| 02/01/2005 | US6849636 Useful for treatment of noninsulin-dependent diabetes, hyperglycemia, obesity, insulin resistance, dyslipidemia, hyperlipidemia, hypertension, Metabolic Syndrome |
| 02/01/2005 | US6849633 Pyrazole derivative, production process thereof, and pest control agent containing the same as active ingredient |
| 02/01/2005 | US6849631 Semicarbazides and their uses |
| 02/01/2005 | US6849629 Heteroaromatic substituted sulfonyl or sulfoxide or thio-pyridazinone derivatives, useful for treating diabetic complications and cardiovascular disorders |
| 02/01/2005 | US6849625 Use in manufacture of a medicament for use as an anti-invasive agent in containment and/or treatment of solid tumor disease |
| 02/01/2005 | US6849622 May be useful for the prophylaxis and treatment of diabetes, particularly type 2 diabetes, and for prophylaxis and treatment of other diseases induced or exacerbated by impaired glucose tolerance |
| 02/01/2005 | US6849621 Treating: allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep |
| 02/01/2005 | US6849367 Photoconductive layer containing azo compound; electrostaticlatent image |
| 02/01/2005 | US6849116 Containing 1 or 2 phthalimido groups |
| 02/01/2005 | CA2166326C Pyridazinone derivatives |
| 01/27/2005 | WO2005007652A2 Substituted quinolin-4-ylamine analogues |
| 01/27/2005 | WO2005007648A2 Biaryl piperazinyl-pyridine analogues |
| 01/27/2005 | WO2005007647A1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 01/27/2005 | WO2005007646A1 Substituted heterocyclic diarylamine analogues |
| 01/27/2005 | WO2005007645A1 Substituted 4-amino-1-benzylpiperidine compounds |
| 01/27/2005 | WO2005007643A1 Novel acridine derivatives and use thereof as medicaments |
| 01/27/2005 | WO2005007642A2 Novel azaheterocyclic amides useful for treating pain |
| 01/27/2005 | WO2005007641A1 2-pyridine alkyne derivatives useful for treating pain |
| 01/27/2005 | WO2005007629A1 Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activity |
| 01/27/2005 | WO2005007628A1 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 01/27/2005 | WO2005007625A2 Heterocyclic amides with anti-tuberculosis activity |
| 01/27/2005 | WO2005007621A2 Ubiquitin ligase inhibitors |
| 01/27/2005 | WO2005007164A1 Pyrimidine-2,4-dione derivatives as gonadotropin-releasing hormone receptor antagonists |
| 01/27/2005 | WO2005007157A1 Pyrazolines as par-1 antagonists for treatment of cardiovascular diseases |
| 01/27/2005 | WO2005007111A2 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 01/27/2005 | WO2004101512A3 Naphthyridine integrase inhibitors |
| 01/27/2005 | WO2004100949A3 Solid-state forms of 5-(difluoromethoxy)-2-((3,4-dimethoxy-2-pyridinyl)methyl)sulfinyl)-1h-benzimidazole (pantoprazole) sodium aqua complexes |
| 01/27/2005 | WO2004099130A3 1,2-diarylimidazoles useful as inhibitors of cox |
| 01/27/2005 | WO2004098518A3 Pyrazole-amide compounds useful as kinase inhibitors |
| 01/27/2005 | WO2004087647A3 4-substituted quinolein derivatives with antimicrobial activity |
| 01/27/2005 | WO2004085418A3 Xanthones, thioxanthones and acridinones as dna-pk inhibitors |
| 01/27/2005 | WO2004069794B1 New arylpiperazinyl compounds |
| 01/27/2005 | WO2004064972A3 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 01/27/2005 | US20050020849 via non-racemic cinchona-alkaloid-type catalyst (quinidine) for addition of nucleophile |
| 01/27/2005 | US20050020836 For therapy of hyperproliferative disorder in a mammal |
| 01/27/2005 | US20050020832 For therapy of atherosclerosis |
| 01/27/2005 | US20050020659 Substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists |
| 01/27/2005 | US20050020652 For example, 2-(4-{2-[1-(4-tert-Butyl-benzyl)-3-methyl-2-oxo-imidazolidin-4-yl]-ethoxy}-2-methyl-phenoxy)-2-methyl-propionic acid, 2-(4-{3-[1-(4-tert-Butyl-benzyl)-3-methyl-2-oxo-imidazolidin-4-yl]-propyl}-2-methyl-phenoky)-2-methyl-propionic acid; for treating diabetes mellitus |
| 01/27/2005 | US20050020648 "PGI2-preferring" (IP) receptors; p-(imidazolin-2-ylamino-optional alkyl)phenyl p'-substituted ethers or sulfides, e.g., 4,5-Dihydro-1H-imidazol-2-yl)-[4-(4-isopropoxy-phenylsulfanyl)-phenyl]-amine, used to induce hyperalgesia |
| 01/27/2005 | US20050020644 Bicyclic fused pyridinyl amides and advantagesous compositons thereof for use as fungicides |
| 01/27/2005 | US20050020638 Method of stabilizing lansoprazole |
| 01/27/2005 | US20050020636 Antitumor agents |
| 01/27/2005 | US20050020629 Pain management |
| 01/27/2005 | US20050020626 9- or 10-membered bicyclic N-heteroaryl carboxamides, N-substituted with 4-[2-(o-methylthiophenoxy)pyridin-3-ylcarbonylamino]cyclohexyl groups, e.g., Pyrazolo[1,5-a]pyridine-2-carboxylic acid(4-{[5-fluoro-2-(3-methylsulfanyl-phenoxy)-pyridine-3-carbonyl]-amino}-cyclohexyl)-amide; respiratory disorders |
| 01/27/2005 | US20050020625 Blocking starting compound with metal alkoxide; anticancer agents |
| 01/27/2005 | US20050020606 2,4-Bis (trifluoroethoxy)pyridine compound and drug containing the compound |
| 01/27/2005 | US20050020605 Quinolyl amide derivatives as CCR-5 antagonists |
| 01/27/2005 | US20050020604 5-HT receptor ligands and uses thereof |
| 01/27/2005 | US20050020602 Bone disorders; reduction concentration of parathyroid hormone in blood |
| 01/27/2005 | US20050020601 Novel pyrazinones as CRF1 receptor antagonists |
| 01/27/2005 | US20050020597 Attention deficit disorders; hyperactivity; post-trauma stress disorders; anxiolytic agents; obsessive compulsive disorders; analgesics; Parkinson's disease |